EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Tumor Cell‐Derived CXCL2 Potentiates Neutrophil‐Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular Carcinoma

Xin Liu, Danli Yang, Qianqian Jiang, Meng Han, Zhao Zhou, Yukun Li, Yu Wu, Jingzhou Wang, Ting Zhang, Guohua Lou, Guochao Wei, Lin Wang und 2 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202511436 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Xin Liu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Infectious Disease Research Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Chemokine CXCL2, Liver Neoplasms, Neutrophils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) is a major cause of cancer‐related death worldwide. Despite the proven efficacy of immunotherapy against malignancies, a large proportion of patients with HCC fail to benefit from these efficacious agents because of their overwhelmingly immunosuppressive microenvironment. Therefore, there is an urgent need to identify key genes and develop effective strategies for reshaping the HCC microenvironment. Here, a significant downregulation of C‐X‐C motif chemokine ligand 2 (CXCL2) in HCC is identified due to gene copy number loss, which correlates with poor prognosis and suboptimal responsiveness to immunotherapy. Subsequently, it is found that CXCL2 can not only recruit neutrophils as expected, but also induce their polarization toward the antitumor type to curb HCC progression. Mechanistically, differing from the prevailing notion that CXCL2 primarily functions extracellularly as a chemokine, it is demonstrated that intracellular CXCL2 can bind to Y‐Box Binding Protein 1 (YBX1) and prevent its nuclear translocation. Consequently, this reduces the transcription of sterol regulatory element binding transcription factor 2 (SREBF2) and suppresses cholesterol biosynthesis, thereby remodeling HCC microenvironment and impeding HCC development. In summary, this study highlights the unconventional role of CXCL2 in regulating neutrophil polarization and immune responses in HCC, positioning it as a potential therapeutic target for HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularChemokine CXCL2Liver NeoplasmsNeutrophilsCholesterolHumansMiceAnimalsTumor MicroenvironmentCell Line, Tumor

Stichwörter der Autor:innen

C‐X‐C motif chemokine ligand 2 (CXCL2)cholesterol metabolismneutrophilpolarization

Substanzen

Chemokine CXCL2CholesterolCXCL2 protein, human

Autor:innen und Institutionen

  • Department of Microbiology and Infectious Disease Research Center, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
  • Peking University Hepatology Institute, Peking University People's Hospital, Beijing, 100044, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Centre for Infectious Diseases, Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, The…

ORCID-Profile: Xiangmei Chen

Förderung

  • National Key R&D Program of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Liu, X., Yang, D., Jiang, Q., Han, M., Zhou, Z., Li, Y., Wu, Y., Wang, J., Zhang, T., Lou, G., Wei, G., Wang, L., Lu, F., & Chen, X. (2026). Tumor Cell‐Derived CXCL2 Potentiates Neutrophil‐Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular Carcinoma. Advanced Science. https://doi.org/10.1002/advs.202511436

Vancouver

Liu X, Yang D, Jiang Q, Han M, Zhou Z, Li Y, et al. Tumor Cell‐Derived CXCL2 Potentiates Neutrophil‐Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular Carcinoma. Advanced Science. 2026. doi:10.1002/advs.202511436

BibTeX
@article{Liu2026,
  author = {Liu, Xin and Yang, Danli and Jiang, Qianqian and Han, Meng and Zhou, Zhao and Li, Yukun and Wu, Yu and Wang, Jingzhou and Zhang, Ting and Lou, Guohua and Wei, Guochao and Wang, Lin and Lu, Fengmin and Chen, Xiangmei},
  title = {Tumor Cell‐Derived CXCL2 Potentiates Neutrophil‐Mediated Antitumor Immunity by Inhibiting Cholesterol Biosynthesis in Hepatocellular Carcinoma},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202511436}
}
Kostenlos starten →